Food Effect Bioavailability Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets

Clinical trial NCT05416957 · COMPLETED

Trial details

NCT number: NCT05416957
Sponsor: Seasons Biotechnology (Taizhou) Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Major Depressive Disorder (MDD)

Start date: 2022-09-18
Primary completion: 2022-10-27
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.